TrialJournal of internal medicine2021

Cyclosporine A plus low-dose steroid treatment in COVID-19 improves clinical outcomes in patients with moderate to severe disease: A pilot study.

J L Gálvez-Romero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.